These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 2249319

  • 1. [Pulmonary changes in progressive systemic sclerosis].
    Yao WZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):157-9, 191. PubMed ID: 2249319
    [Abstract] [Full Text] [Related]

  • 2. Lung involvement in systemic sclerosis.
    Silver RM, Miller KS.
    Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The correlations of respiratory function tests, chest roentgenographic manifestations and respiratory symptoms in the patients with systemic sclerosis, using a scoring-method for symptoms].
    Kikuchi K, Igarashi A, Ishibashi Y, Inokuma S, Takehara K.
    Nihon Hifuka Gakkai Zasshi; 1990 May; 100(6):695-700. PubMed ID: 2214236
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Pulmonary involvement in sclerodermia].
    Paone G, Di Michele L, Mattia P, Tonnarini R, Lucifora V, Fiorucci F.
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
    Owens GR, Paradis IL, Gryzan S, Medsger TA, Follansbee WP, Klein HA, Dauber JH.
    J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
    [Abstract] [Full Text] [Related]

  • 11. [Collageno-vascular diseases and interstitial pulmonary fibrosis. An analysis of diagnostic tests].
    Baldi S, Rapellino M, Libertucci D, Obert R, Scappaticci E, Coni F, Revello F, Oliaro A, Botto-Micca F.
    Minerva Med; 1987 Sep 15; 78(17):1277-80. PubMed ID: 3670681
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.
    Arthritis Rheum; 2006 Dec 15; 54(12):3962-70. PubMed ID: 17133610
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
    Sato S, Komura K, Hasegawa M, Fujimoto M, Takehara K.
    J Rheumatol; 2001 Nov 15; 28(11):2460-5. PubMed ID: 11708419
    [Abstract] [Full Text] [Related]

  • 14. Latent pulmonary inflammation in patients with systemic sclerosis.
    Sánchez-Vidaurre S, Simeón CP, Cruz MJ, Fonollosa V, Vilardell M, Morell F, Muñoz X.
    Arch Bronconeumol; 2012 Jan 15; 48(1):8-13. PubMed ID: 22133713
    [Abstract] [Full Text] [Related]

  • 15. [Two cases of intrapulmonary lymph node associated with either progressive systemic sclerosis or idiopathic pulmonary fibrosis].
    Yoshitomi A, Sato A, Toyoshima M, Suganuma H, Imokawa S, Tamura R, Suda T, Yagi T, Hayakawa H, Chida K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Sep 15; 33(9):1003-8. PubMed ID: 8538080
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serial changes in scleroderma and idiopathic interstitial lung disease.
    Colp CR, Riker J, Williams MH.
    Arch Intern Med; 1973 Oct 15; 132(4):506-15. PubMed ID: 4742404
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease.
    Várai G, Earle L, Jimenez SA, Steiner RM, Varga J.
    J Rheumatol; 1998 Jul 15; 25(7):1325-9. PubMed ID: 9676764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.